Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF) has revealed strong demand for its coronavirus (COVID-19) testing solutions at the port of Vancouver.
The healthcare company said that it has conducted more than 3,000 tests and confirmed more than 750 pending appointments in its first full month of operations.
Vancouver is a leading homeport for cruises to Alaska and is the only port to offer both one-way and roundtrip itineraries through Canada's Inside Passage to Alaska.
READ: Empower Clinics files trademark application in the US Patent and Trademark Office for the mark 'Medisure'
Empower's fully accredited COVID-19 testing solutions includes three certified sites at the Port of Vancouver, Canada Place and Fairmont Waterfront Hotel as well as a recently accredited concierge mobile service.
According to Empower, the Vancouver Fraser Port Authority expects more than 300 cruise ship calls for the 2022 season - nearly an 8% increase from 288 calls in pre-pandemic 2019. Multiple ships carry more than 4,000 passengers.
"Serving well over 3,000 clients is an important milestone for our accredited testing solutions in Vancouver providing significant new cash flow for the company and supporting our investment thesis for this project," Steven McAuley, CEO of Empower said in a statement.
"It reasserts the importance and investment that we've made to be a fully accredited operation as per local BC regulation. It also allows our entire team, clients and shareholders to find confidence in the stability, quality and potential reach of our services while we are still early in the cruise season and peak tourist season for Vancouver - with countless conferences, tour groups and events - just ahead of us."
Vancouver-based Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories.
Contact Angela at angela@proactiveinvestors.com
Follow her on Twitter @AHarmantas